VIMTALABSNSEVimta Labs Limited· PharmaceuticalsMinimalNeutral
Announced Thu, 7 May · 18:27 IST

Vimta Labs Limited has informed the Exchange about Copy of Newspaper Publication

VIMTALABS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-2.4%1-day move
₹504.00
prior close
₹505.85
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.7+1.7+2.4+3.2-2.4-7.1-7.3-9.2-9.8-10.2-9.1+3.8+6.7
Up moveDown movePending
AI summary

Vimta Labs Limited published its audited financial results for Q4 and full year ended March 31, 2026, in Business Standard (English All editions) and Nava Telangana (Telugu) newspapers on May 7, 2026. The Board of Directors, on recommendation of the Audit Committee, approved these results at their meeting held on May 6, 2026. The filing complies with Regulation 33 and 47 of the SEBI (LODR) Regulations, 2015. The full financial results along with the Auditors' Report (including unmodified opinion) are available on the company's website and on BSE and NSE websites. Vimta Labs is a life sciences testing and research services company headquartered in Hyderabad.

Likely market impact

Routine regulatory filing confirming newspaper publication of audited Q4 and FY2026 results. No material new financial information disclosed beyond what was already filed with stock exchanges.